🇺🇸
United States · US · US:82292-040_8a6aec36-4e75-4cd0-a250-cb126128bbd4
LUMISIGHT
Orange BookUNIISPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerLumicell, Inc.
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc11822920401010 VIAL in 1 CARTON (82292-040-10) / 3.9 mL in 1 VIAL (82292-040-01)
Annotations
UNII (FDA Substance ID)
T6HE85WN0Q
PEGULICIANINE
Orange Book
N214511
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "T6HE85WN0Q",
"rxcui": null,
"inchikey": null,
"display_name": "PEGULICIANINE",
"substance_type": "polymer",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"7160e774-663a-43e4-ba4a-06cc57830e66": {
"match": "brand_token",
"title": "LUMISIGHT (PEGULICIANINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [LUMICELL, INC.]",
"spl_version": "3",
"published_date": "2026-01-12"
}
},
"productid": "82292-040_8a6aec36-4e75-4cd0-a250-cb126128bbd4",
"productndc": "82292-040",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"orange_book": {
"appl_no": "214511",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 39MG BASE/VIAL",
"product_no": "001",
"approval_date": "Apr 17, 2024"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "PEGULICIANINE",
"proprietary_name": "LUMISIGHT",
"active_ingred_unit": "mg/mL",
"application_number": "NDA214511",
"marketing_category": "NDA",
"nonproprietary_name": "Pegulicianine",
"start_marketing_date": "20240417",
"active_numerator_strength": "10"
}Access this data programmatically
Query LUMISIGHT and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.